This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Spitfire Pharma, Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Omar Roble Olhaye: Innovator in Therapeutic Regimens
Introduction
Omar Roble Olhaye is a notable inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of therapeutic regimens, particularly in the management of blood glucose and body weight.
Latest Patents
Olhaye holds a patent for "Therapeutic regimens and methods for lowering blood glucose and/or body weight using GLP-1R and GCGR balanced agonists." This patent relates to a once-weekly dosing regimen of a dual GLP-1R and GCGR agonist, along with formulations and methods for treating chronic weight management, obesity, and blood glucose control. The patent includes a dual agonist peptide product of SEQ ID NO. 1, showcasing his innovative approach to addressing these health issues.
Career Highlights
Omar Roble Olhaye is currently associated with Spitfire Pharma, Inc., where he continues to develop and refine his therapeutic methods. His work is pivotal in advancing treatments that can significantly impact patients' lives.
Collaborations
Olhaye collaborates with talented professionals in his field, including Vyjayanthi Krishnan and Joyce James. Their combined expertise contributes to the innovative environment at Spitfire Pharma, Inc.
Conclusion
Omar Roble Olhaye's contributions to therapeutic regimens highlight his commitment to improving health outcomes through innovation. His work in developing methods for managing blood glucose and body weight is a testament to his dedication as an inventor.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile